Outcomes after implantation of partial-support left ventricular assist devices in inotropic- dependent patients: Do we still need full-support assist devices?

Slides:

Advertisements

Similar presentations

Manuel J. Antunes, MD, PhD, DSc

Advertisements

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Nikhil Prakash Patil, MRCS, MCh, Anton Sabashnikov, MD, Prashant N

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

The RECOVER I: A multicenter prospective study of Impella 5

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

Outcome of 200 patients after an extracardiac Fontan procedure

Use of trifurcate arch graft in left ventricular assist device implantation via the sternal sparing approach Prashant N. Mohite, MCh, Diana Garcia-Saez,

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Evaluation of the Organ Care System in Heart Transplantation With an Adverse Donor/Recipient Profile Diana García Sáez, MD, Bartlomiej Zych, MD, Anton.

Early readmission for congestive heart failure predicts late mortality after cardiac surgery Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei,

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Prolonged QTc affects short-term and long-term outcomes in patients with normal left ventricular function undergoing cardiac surgery Nattachai Anantasit,

Building a bioartificial heart: A 3-song saga

Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome Soren Schenk, MD, Patrick M. McCarthy,

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Marye J. Gleva, MD, Charles B. Huddleston, MD

Resuscitation practices in cardiac surgery

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

The lord of the rings Antonio Miceli, MD, PhD

A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients Khanh Nguyen, MD The Journal.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Abdul Rahman Dakkak, MD, Angelo M. Dell'Aquila, MD, Juergen R

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

Commentary: Faster recovery after complex neonatal cardiac surgery

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory Christopher P. Fagundes, PhD, Qiuling.

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

James O. O’Neill, MB, Randall C

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Jay K. Bhama, MD, Utsav Bansal, BS, Daniel G. Winger, MS, Jeffrey J

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

The continuing challenge of congenital heart disease in China

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

James W. Long, MD, PhD, Aaron H. Healy, BS, Brad Y

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Heidi Goerler, MD, Andre Simon, MD, Gregor Warnecke, MD, Anna L

“The more things change…”: The challenges ahead

Why arch curvature affects arch resistance

Clinical Experience With HeartWare Left Ventricular Assist Device in Patients With End- Stage Heart Failure Aron Frederik Popov, MD, Morteza Tavakkoli.

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Did you like Terminator 3 better than Terminator 2

A good chimney requires a good sweep

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

How do we follow up our patients

Hari R. Mallidi, MD The Journal of Thoracic and Cardiovascular Surgery

Lessons learned from Melody valve retrieved at transplantation

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Presentation transcript:

Outcomes after implantation of partial-support left ventricular assist devices in inotropic- dependent patients: Do we still need full-support assist devices? Anton Sabashnikov, MD, Aron-Frederik Popov, MD, PhD, Christopher T. Bowles, PhD, Prashant N. Mohite, MCh, Alexander Weymann, MD, PhD, Rachel Hards, BS, Mike Hedger, BS, Thorsten Wittwer, MD, PhD, Jens Wippermann, MD, PhD, Thorsten Wahlers, MD, PhD, Friedrich A. Schoendube, MD, PhD, André R. Simon, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 3, Pages 1115-1122 (September 2014) DOI: 10.1016/j.jtcvs.2014.05.063 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Kaplan–Meier survival curve for the entire cohort of patients who underwent partial-support LVAD implantation. Patients are censored for cardiac transplantation, device explantation for myocardial recovery, device exchange, and at the cutoff of the study. Twenty-day, 6-month, 1-year, and 2-year cumulative survivals with respective numbers of patients at risk are shown. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1115-1122DOI: (10.1016/j.jtcvs.2014.05.063) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions